Key technologies and capabilities for this role
Common questions about this position
This is an onsite role at the company's San Diego headquarters.
A Ph.D. in Biochemistry, Molecular Biology, Chemical Biology, or a related field is required, along with 7+ years of postdoctoral or industry experience in molecular assay or reagent development. Candidates need a strong background in nucleic acid and/or protein biochemistry, particularly in tissue-based or in situ assays, hands-on experience with tissue sample preparation, in situ hybridization, immunostaining, or enzymatic labeling, and industry experience in tissue-based product development.
Element Biosciences has built a highly efficient product-driven organization where employees can learn, grow, and thrive in a challenging but encouraging environment, with commitments to scientific integrity, collegiality, honesty, objectivity, and openness.
This information is not specified in the job description.
Strong candidates possess a Ph.D. with 7+ years of experience in molecular assay or reagent development, hands-on expertise in tissue-based assays like in situ hybridization and immunostaining, and industry experience in product development including reagent formulation and workflow optimization.
Next-generation sequencing technology provider
Element Biosciences focuses on next-generation sequencing (NGS) technology, offering the AVITI System, a compact benchtop device that provides high-quality sequencing at a low cost of $1 per million reads. This system is designed for various clients, including academic researchers and pharmaceutical companies, and delivers industry-leading accuracy. Element Biosciences stands out by partnering with other biotech firms, like QIAGEN, to provide complete NGS workflows and by offering the 2023 AVITI for All Grant, which gives free sequencing for diverse applications. The company's goal is to make high-quality sequencing accessible and affordable to accelerate advancements in biotechnology.